A New Non-Invasive Breast Cancer Diagnostic Test
Listen now
Description
In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, spoke with Judit Giró Benet, co-founder and CEO of The Blue Box, for an in-depth discussion on breast cancer diagnostics, with a focus on non-invasive testing. Topics touched on during their conversation include: Using urine to identify breast cancer biomarkers The distinctions between mammographies and liquid biopsies for cancer detection  The importance of accessibility for breast cancer testing How the natural world influenced the development of The Blue Box.
More Episodes
In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski interviews Jeff Andrews, MD, FRCSC, a board-certified gynecologist and vice president of Global Medical Affairs for Diagnostic Solutions at BD, what HPV sample self-collection means for the diagnosis, prevention,...
Published 10/02/24
Published 10/02/24
In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics. Among the topics they dig into are: The benefits of...
Published 09/27/24